Rapcabtagene Autoleucel

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Rapcabtagene Autoleucel, covering 2026-02-20 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL [Phase 1, Phase 2]